Jonathan Golledge Selected Research

Intermittent Claudication

1/2022	Cohort Study Examining the Association of Immunosuppressant Drug Prescription With Major Adverse Cardiovascular and Limb Events in Patients With Peripheral Artery Disease.
1/2021	Network Meta-Analysis Comparing the Outcomes of Treatments for Intermittent Claudication Tested in Randomized Controlled Trials.
1/2021	Protocol for the Stimulating β3-Adrenergic Receptors for Peripheral Artery Disease (STAR-PAD) trial: a double-blinded, randomised, placebo-controlled study evaluating the effects of mirabegron on functional performance in patients with peripheral arterial disease.
1/2017	Effect of blood pressure lowering medications on leg ischemia in peripheral artery disease patients: A meta-analysis of randomised controlled trials.
3/2014	Potential vascular mechanisms of ramipril induced increases in walking ability in patients with intermittent claudication.
1/2014	Serum endostatin concentrations are higher in men with symptoms of intermittent claudication.
11/2013	Lower plasma testosterone or dihydrotestosterone, but not estradiol, is associated with symptoms of intermittent claudication in older men.
6/2013	Peripheral arterial disease - diagnosis and management in general practice.
2/2013	Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial.
11/2011	A meta-analysis of the outcome of endovascular and noninvasive therapies in the treatment of intermittent claudication.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathan Golledge Research Topics

Disease

91	Abdominal Aortic Aneurysm 01/2022 - 06/2005
29	Stroke (Strokes) 11/2022 - 02/2002
28	Atherosclerosis 01/2019 - 07/2004
27	Peripheral Arterial Disease 01/2022 - 08/2006
26	Inflammation (Inflammations) 01/2022 - 12/2006
23	Myocardial Infarction 07/2022 - 02/2008
20	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 05/2008
19	Aneurysm (Aneurysms) 12/2021 - 06/2005
18	Hypertension (High Blood Pressure) 01/2022 - 01/2007
16	Aortic Aneurysm (Aneurysm, Aortic) 01/2021 - 03/2007
15	Rupture 12/2021 - 11/2009
13	Thrombosis (Thrombus) 01/2021 - 09/2008
12	Intermittent Claudication 01/2022 - 01/2007
11	Atherosclerotic Plaque (Atheroma) 01/2022 - 05/2007
6	Carotid Artery Diseases 07/2022 - 07/2004
6	Neoplasms (Cancer) 11/2020 - 01/2014
6	Coronary Disease (Coronary Heart Disease) 05/2014 - 02/2008
6	Vascular Diseases (Vascular Disease) 07/2013 - 08/2007
5	Foot Diseases 10/2022 - 08/2020
5	Infections 03/2022 - 10/2015
5	Wounds and Injuries (Trauma) 03/2022 - 10/2015
5	Ischemia 01/2021 - 05/2013
4	Foot Ulcer 01/2021 - 01/2016
4	Type 2 Diabetes Mellitus (MODY) 01/2021 - 11/2014
4	Heart Failure 11/2020 - 03/2012
4	Dyslipidemias (Dyslipidemia) 10/2018 - 05/2010
4	Aortic Rupture 01/2018 - 12/2014
4	Vascular Calcification 01/2011 - 03/2008
3	Transient Ischemic Attack 07/2022 - 01/2022
3	Frailty 01/2022 - 03/2021
3	Pain (Aches) 01/2022 - 10/2008
3	Ulcer 05/2021 - 01/2016
3	Ischemic Stroke 12/2019 - 04/2014
3	Thyroid Diseases (Thyroid Disease) 01/2018 - 10/2013
3	Lung Neoplasms (Lung Cancer) 02/2017 - 01/2014

Drug/Important Bio-Agent (IBA)

29	Angiotensin IIIBA 01/2021 - 07/2004
20	Biomarkers (Surrogate Marker)IBA 08/2021 - 08/2007
19	ApolipoproteinsIBA 01/2020 - 07/2009
13	LipidsIBA 07/2022 - 01/2007
12	CytokinesIBA 01/2022 - 06/2005
12	Apolipoproteins E (ApoE)IBA 11/2019 - 04/2010
11	OsteoprotegerinIBA 01/2018 - 07/2004
10	omega-Chloroacetophenone (Mace)IBA 01/2022 - 05/2008
10	HomocysteineIBA 03/2021 - 02/2008
9	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 06/2005
9	Proteins (Proteins, Gene)FDA Link 04/2016 - 07/2004
8	Fenofibrate (CiL)FDA LinkGeneric 01/2020 - 05/2007
8	OsteopontinIBA 01/2020 - 07/2004
7	Testosterone (Sustanon)FDA Link 03/2021 - 03/2010
7	C-Reactive ProteinIBA 03/2021 - 01/2007
6	Peptides (Polypeptides)IBA 01/2021 - 09/2011
6	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2020 - 03/2011
6	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020 - 05/2007
6	LigandsIBA 01/2019 - 05/2007
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2022 - 12/2006
5	Telmisartan (Micardis)FDA Link 01/2022 - 06/2015
5	CholesterolIBA 11/2021 - 03/2008
5	Antihypertensive Agents (Antihypertensives)IBA 11/2020 - 07/2014
5	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2018 - 07/2014
5	Estradiol (Delestrogen)FDA LinkGeneric 01/2017 - 11/2013
4	diformyl dapsone (DFD)IBA 10/2022 - 08/2020
4	LDL CholesterolIBA 07/2022 - 12/2019
4	oxidized low density lipoproteinIBA 07/2022 - 01/2008
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 09/2011
4	OsteocalcinIBA 01/2021 - 05/2010
4	Scarlet Red (Sudan IV)IBA 10/2018 - 12/2010
4	MicroRNAs (MicroRNA)IBA 03/2018 - 06/2014
4	fibrin fragment D (D-dimer)IBA 01/2018 - 02/2011
4	Transforming Growth Factor beta (TGF-beta)IBA 01/2018 - 04/2010
4	CreatinineIBA 01/2018 - 09/2009
4	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2018 - 10/2013
4	Dihydrotestosterone (Androstanolone)IBA 01/2017 - 11/2013
4	Phenobarbital (Luminal)FDA Link 02/2012 - 05/2008
3	Metformin (Glucophage)FDA LinkGeneric 12/2021 - 01/2019
3	Uric Acid (Urate)IBA 11/2021 - 12/2017
3	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 11/2014
3	Vitamin D FDA LinkGeneric 03/2021 - 01/2014
3	Angiotensin Receptor AntagonistsIBA 01/2021 - 06/2015
3	KininsIBA 01/2021 - 01/2016
3	Pancreatic Elastase (Elastase)IBA 01/2021 - 12/2014
3	AdipokinesIBA 01/2021 - 01/2007
3	AndrogensIBA 01/2020 - 11/2013
3	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2020 - 12/2014
3	CollagenIBA 10/2018 - 03/2008
3	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2018 - 02/2017
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018 - 11/2011
3	Carrier Proteins (Binding Protein)IBA 01/2018 - 04/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2016 - 03/2014
3	ElastinIBA 04/2016 - 01/2007
3	UrocortinsIBA 04/2014 - 09/2011
3	PPAR gammaIBA 10/2010 - 01/2009

Therapy/Procedure

25	Therapeutics 01/2022 - 09/2007
12	Surgical Amputation (Amputations) 01/2022 - 11/2008
11	Drug Therapy (Chemotherapy) 01/2022 - 12/2010
6	Carotid Endarterectomy 11/2022 - 05/2007
4	Subcutaneous Infusions 01/2017 - 07/2009
3	Vascular Surgical Procedures 11/2022 - 01/2019
3	Ligation 05/2013 - 01/2010
3	Stents 03/2011 - 08/2006
2	Secondary Prevention 10/2022 - 05/2022